About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT02229097

Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic Patients

A recent study suggests that, in Type 1 Diabetes (T1D) patients treated by insulin pumps, a better coordination of meal boluses and post prandial basal rate could reduce the importance of postprandial...

Lead sponsor: University Hospital, Toulouse•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Toulouse

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Type 1 diabetes mellitus
•with confirmed Negative C-peptide or diabetes duration\>5 years
•Treated by external insulin pump and rapid insulin analog for more than 3 months
•using a Medtronic Paradigm Real-Time or Veo™ model
•Educated to and practicing functional insulin treatment and carbohydrate counting for more than 3 months
•Able to use the "basal temp" and "glycaemia reminder" functions of their pump
•Basal infusion rate ≥ 0,5 Unit/h
•Self-monitoring of blood glucose frequency \> 4/days
•Aware of hypoglycaemia

Exclusion Criteria

•known impaired renal function (creatinin clearance \<60ml/min)
•Gastroparesis
•Serious or instable disease likely to induce a glycaemic control deterioration - treatment with corticosteroids

Related studies

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Automated Insulin for Management of Intrapartum Glycemia

NCT06883344 · Type 1 Diabetes (T1D), Pregnancy, and more

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

Long-Term Outcomes of Teplizumab in Routine Clinical Care

NCT07360080 · Type 1 Diabetes

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580 · Type 1 Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 23, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment17

Start dateOct 2014

Last updatedFeb 23, 2017

Condition

Type 1 Diabetes

Locations shown

University Hospital Toulouse Rangueil

Toulouse, Haute Garonne

Saint-André Hospital

Bordeaux

Lapeyronie Hospital

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2017Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions